Cytotrait lands fresh funding for next‑gen crop engineering
UK-based agritech startup Cytotrait has raised £3 million to advance its organelle engineering platform, targeting major staple crops such as wheat, maize and potatoes. The new capital will be used to refine the company’s technology, expand field trials and accelerate partnerships with global seed and farming businesses.
Organelle engineering moves from lab to field
Cytotrait focuses on engineering plant organelles – the energy and metabolic hubs inside cells, such as chloroplasts and mitochondria – rather than altering only nuclear DNA. By precisely tuning how these organelles process light, nutrients and stress, the startup aims to deliver crops with higher yields, improved nutrient-use efficiency and better resilience to drought, heat and disease.
This approach is positioned as a next generation of crop biotechnology, complementing existing genome editing and traditional breeding. Because organelles have distinct genetic systems and inheritance patterns, engineering them can, in some cases, offer more contained and predictable traits, which may appeal to both regulators and large-scale producers.
Focus on wheat, maize and potatoes
The initial pipeline centres on wheat, maize and potatoes, three crops that underpin global food security and are heavily exposed to climate change. Cytotrait plans to demonstrate that its organelle-based traits can increase productivity while reducing the need for inputs such as fertiliser and crop protection chemicals.
Industry analysts note that if organelle engineering delivers consistent performance gains in these high-volume crops, it could unlock significant value across the global agriculture and food supply chain, from seed companies to processors and retailers.
Positioning in the agritech investment landscape
The £3 million round underscores continued investor interest in technologies that can make farming more resilient and sustainable. While terms and investors were not disclosed in the source material, the deal places Cytotrait among a growing cohort of European startups using advanced synthetic biology and AI-driven trait discovery to tackle yield plateaus and environmental pressures.
With fresh funding in place, the company is expected to deepen collaborations with research institutions and commercial partners as it works toward regulatory approval and large-scale deployment on farms.